Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nuriye Yildirim, Ozdemir"'
Autor:
Nebi Serkan Demirci, Eyyup Cavdar, Nuriye Yildirim Ozdemir, Sinemis Yuksel, Yakup Iriagac, Gokmen Umut Erdem, Hatice Odabas, Ilhan Hacibekiroglu, Mustafa Karaagac, Mahmut Ucar, Banu Ozturk, Yakup Bozkaya
Publikováno v:
Medicina, Vol 60, Iss 5, p 818 (2024)
Background and Objectives: In ampullary cancer, 5-year survival rates are 30–50%, even with optimal resection and perioperative systemic therapies. We sought to determine the important clinicopathological features and adjuvant treatments in terms o
Externí odkaz:
https://doaj.org/article/8626dfe6c0064ba792f099060c6a66fb
Autor:
Suayib Yalcin, Faysal Dane, Berna Oksuzoglu, Nuriye Yildirim Ozdemir, Abdurrahman Isikdogan, Metin Ozkan, Guzin Gonullu Demirag, Hasan Senol Coskun, Bulent Karabulut, Turkkan Evrensel, Mehmet Ali Ustaoglu, Feyyaz Ozdemir, Hande Turna, Tugba Yavuzsen, Faruk Aykan, Alper Sevinc, Hakan Akbulut, Deniz Yuce, Mutlu Hayran, Saadettin Kilickap
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Combination of gemcitabine and nab-paclitaxel has superior clinical efficacy than gemcitabine alone. Nevertheless, health-related quality of life. (QoL) associated with this combination therapy when administered at first-line in a
Externí odkaz:
https://doaj.org/article/1ae3c043ebb54a6c82250c0cb4ea7be9
Autor:
Tulay Kus, Fatih Kose, Gokmen Aktas, Ulku Yalcintas Arslan, Ali Murat Sedef, Havva Yesil Cinkir, Merve Dirikoc, Gulsum Akkus, Nuriye Yildirim Ozdemir
Publikováno v:
Journal of Oncological Sciences, Vol 5, Iss 3, Pp 80-84 (2019)
Aim: While the main treatment of gastric cancer (GC) is surgery, controversy continues regarding appropriate lymph nodes dissection (LND) types and optimal adjuvant therapy after surgery. Therefore, we aim to analyze the survival outcomes of differen
Externí odkaz:
https://doaj.org/article/82bc304d40f34b46bd46ad3df5ee0c6d
Autor:
Yakup, Ergun, Nuriye, Yildirim Ozdemir, Serife, Toptas, Alican, Kurtipek, Tulay, Eren, Ozan, Yazici, Mehmet Ali, Sendur, Bulent, Akinci, Gokhan, Ucar, Berna, Oksuzoglu, Dogan, Uncu
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 24(4)
Tyrosine kinase inhibitors (TKIs) are frequently used drugs in oncology practice. Although oral administration is an advantage, long-term use increases potential drug-drug interaction risk. The purpose of this study was to assess the prevalence of po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3c5b05a2e68cdb64fc7af842d90f3224
https://pubmed.ncbi.nlm.nih.gov/31646831
https://pubmed.ncbi.nlm.nih.gov/31646831
Autor:
Yakup, Ergun, Nuriye Yildirim, Ozdemir, Ebru Karci, Guner, Ece, Esin, Mehmet Ali, Sendur, Elif Berna, Koksoy, Nebi Serkan, Demirci, Tulay, Eren, Isa, Dede, Ahmet, Sezer, Huseyin, Engin, Berna, Oksuzoglu, Bulent, Yalcin, Gungor, Utkan, Nurullah, Zengin, Yuksel, Urun
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 23(7)
Gemcitabine is among the standard first-line agents for the treatment of metastatic pancreatic cancer. However, as the median survival with gemcitabine monotherapy is 6 months, different combinations are being studied for better, prolonged survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e60d20186d66a736f91e0296c3e2579b
https://pubmed.ncbi.nlm.nih.gov/30722120
https://pubmed.ncbi.nlm.nih.gov/30722120
Autor:
Ali Osman, Kaya, Suleyman, Buyukberber, Faysal, Dane, Abdurrahman, Isikdogan, Basak Oven, Ustaalioglu, Ugur, Coskun, Perran Fulden, Yumuk, Gamze Gokoz, Dogu, Nuriye Yildirim, Ozdemir, Alper, Sevinc, Mahmut, Gumus, Metin, Ozkan, Ramazan, Yildiz, Banu, Ozturk, Emel, Yaman, Mustafa, Benekli
Publikováno v:
Tumori Journal. 96:400-404
Aims To evaluate activity and toxicity of cisplatin plus docetaxel combination in the first-line treatment of chemotherapy-naive patients with metastatic non-small cell lung cancer. Patients and methods Between October 2004 and July 2008, 186 patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8720743df9c51e85f919cc77ed44aa23
https://doi.org/10.1177/030089161009600304
https://doi.org/10.1177/030089161009600304
Autor:
Mehmet A N, Sendur, Sercan, Aksoy, Nuriye, Yildirim Ozdemir, Muhammed B, Akinci, Nurullah, Zengin, Kadri, Altundag
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 19(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b95e3081e52e1f0d15e54e6002b3515b
https://pubmed.ncbi.nlm.nih.gov/24965426
https://pubmed.ncbi.nlm.nih.gov/24965426
Autor:
Mesut, Seker, Alper, Sevinc, Ramazan, Yildiz, Sener, Cihan, Mehmet Ali, Kaplan, Ayse, Gokdurnali, Faysal, Dane, Emel, Yaman, Halit, Karaca, Dilsen, Colak, Ummugul, Uyeturk, Ahmet, Bilici, Nuriye Yildirim, Ozdemir, Mehmet Emin, Kalender, Dogan, Uncu, Taflan, Salepci, Abdurrahman, Isikdogan, Mustafa, Benekli, Metin, Ozkan, Mahmut, Gumus, Ugur, Coskun, Celalettin, Camci, Berna, Oksuzoglu, Suleyman, Buyukberber
Background/Aims: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasm of the gastrointestinal tract. In an attempt to survey the approximate incidence, clinicopathological characteristics, and immunophenotypic features of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::604dd040822d878ad9bc0a49a950cc0f
https://avesis.erciyes.edu.tr/publication/details/d9844d5a-7a3f-4743-b782-2125ad16a17c/oai
https://avesis.erciyes.edu.tr/publication/details/d9844d5a-7a3f-4743-b782-2125ad16a17c/oai
Autor:
Alper, Sevinc, Mesut, Seker, Ahmet, Bilici, Nuriye Yildirim, Ozdemir, Ramazan, Yildiz, Basak Oven, Ustaalioglu, Mehmet Emin, Kalender, Faysal, Dane, Halit, Karaca, Cengiz, Gemici, Mahmut, Gumus, Suleyman, Buyukberber
Publikováno v:
Hepato-gastroenterology. 58(107-108)
Gastrointestinal stromal tumors (GISTs) are the most common primary mesenchymal neoplasms of the tubular gastrointestinal tract (GI). Here, we present a series of 32 patients diagnosed with a primary neoplasm in addition to GIST, from six different i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::06b3dd76d18f2645a5933cfaf18a8a51
https://pubmed.ncbi.nlm.nih.gov/21830398
https://pubmed.ncbi.nlm.nih.gov/21830398
Autor:
Dogan, Uncu, Nuriye Yildirim, Ozdemir, Sercan, Aksoy, Huseyin, Abali, Berna Cakmak, Oksuzoglu, Burçin, Budakoglu, Ramazan, Yildiz, Nalan, Aslan, Nurullah, Zengin
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 11(6)
Chemotherapy and radiotherapy are approved in clinical practice of adjuvant treatment of gastric carcinoma. In present study, we retrospectively evaluated the efficacy and tolerability of an adjuvant treatment protocol including bi-weekly cisplatin,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6cfb3862941c7971c3a6a64834bcb900
https://pubmed.ncbi.nlm.nih.gov/21338186
https://pubmed.ncbi.nlm.nih.gov/21338186